Cargando…
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and cell death are recognized aspects of PD suggesting that strategies to monitor and modify these processes may improve the m...
Autores principales: | Anderson, Faith L., von Herrmann, Katharine M., Andrew, Angeline S., Kuras, Yuliya I., Young, Alison L., Scherzer, Clemens R., Hickey, William F., Lee, Stephen L., Havrda, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782812/ https://www.ncbi.nlm.nih.gov/pubmed/33398042 http://dx.doi.org/10.1038/s41531-020-00147-6 |
Ejemplares similares
-
Lifestyle Factors and Parkinson's Disease Risk in a Rural New England Case-Control Study
por: Andrew, Angeline S., et al.
Publicado: (2021) -
Slc6a3-dependent expression of a CAPS-associated Nlrp3 allele results in progressive behavioral abnormalities and neuroinflammation in aging mice
por: von Herrmann, Katharine M., et al.
Publicado: (2020) -
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
por: von Herrmann, Katharine M., et al.
Publicado: (2018) -
Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019) -
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)